Amundi reduced its stake in shares of Confluent, Inc. (NASDAQ:CFLT - Free Report) by 0.8% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,986,204 shares of the company's stock after selling 15,841 shares during the period. Amundi owned 0.58% of Confluent worth $46,557,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Cloud Capital Management LLC bought a new stake in Confluent in the first quarter worth $26,000. Versant Capital Management Inc lifted its position in Confluent by 2,458.2% during the 1st quarter. Versant Capital Management Inc now owns 1,714 shares of the company's stock worth $40,000 after acquiring an additional 1,647 shares during the last quarter. SVB Wealth LLC acquired a new position in Confluent during the 1st quarter worth $54,000. GAMMA Investing LLC lifted its position in Confluent by 26.8% during the 1st quarter. GAMMA Investing LLC now owns 3,128 shares of the company's stock worth $73,000 after acquiring an additional 661 shares during the last quarter. Finally, PNC Financial Services Group Inc. lifted its position in Confluent by 39.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 4,053 shares of the company's stock worth $95,000 after acquiring an additional 1,143 shares during the last quarter. 78.09% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on the stock. Cowen lowered shares of Confluent from a "buy" rating to a "hold" rating in a research report on Thursday, July 31st. Piper Sandler cut their price objective on shares of Confluent from $32.00 to $27.00 and set an "overweight" rating for the company in a research report on Thursday, July 31st. Oppenheimer cut their price objective on shares of Confluent from $32.00 to $26.00 and set an "outperform" rating for the company in a research report on Thursday, July 31st. TD Cowen reissued a "hold" rating and issued a $24.00 price target on shares of Confluent in a research report on Thursday, July 31st. Finally, Needham & Company LLC dropped their price target on shares of Confluent from $26.00 to $24.00 and set a "buy" rating for the company in a research report on Thursday, July 31st. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $27.36.
Check Out Our Latest Analysis on Confluent
Insider Buying and Selling
In other Confluent news, CEO Edward Jay Kreps sold 232,500 shares of the stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $18.66, for a total value of $4,338,450.00. Following the sale, the chief executive officer directly owned 377,074 shares in the company, valued at approximately $7,036,200.84. This trade represents a 38.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Rohan Sivaram sold 5,000 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $20.00, for a total transaction of $100,000.00. Following the completion of the sale, the chief financial officer owned 631,596 shares in the company, valued at approximately $12,631,920. This trade represents a 0.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 740,621 shares of company stock valued at $13,595,936. 9.20% of the stock is owned by company insiders.
Confluent Trading Up 1.1%
NASDAQ CFLT traded up $0.21 during trading hours on Friday, hitting $19.66. The company's stock had a trading volume of 1,371,635 shares, compared to its average volume of 6,676,418. The stock has a fifty day moving average of $21.02 and a 200 day moving average of $22.91. Confluent, Inc. has a twelve month low of $15.64 and a twelve month high of $37.90. The firm has a market capitalization of $6.78 billion, a P/E ratio of -20.91 and a beta of 0.97. The company has a quick ratio of 3.98, a current ratio of 3.98 and a debt-to-equity ratio of 1.03.
Confluent (NASDAQ:CFLT - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.01. The business had revenue of $282.29 million for the quarter, compared to analyst estimates of $278.32 million. Confluent had a negative net margin of 29.27% and a negative return on equity of 27.34%. Confluent's revenue was up 20.1% compared to the same quarter last year. During the same period in the prior year, the business posted $0.06 earnings per share. Confluent has set its Q3 2025 guidance at 0.090-0.100 EPS. FY 2025 guidance at 0.360-0.360 EPS. Equities research analysts forecast that Confluent, Inc. will post -0.83 earnings per share for the current fiscal year.
Confluent Company Profile
(
Free Report)
Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.
Featured Articles

Before you consider Confluent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Confluent wasn't on the list.
While Confluent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.